Table 1

Baseline characteristics of study participants in the control (n= 3) and intervention (n= 3) clinics

CharacteristicControl (n = 945)Intervention (N = 756)
Sex (female, No. (%))512 (54.2)441 (58.3)
Age (mean (SD), year)55 (17.3)58 (18.4)
18–39 (No. (%))215 (22.7)160 (21.1)
 40–59 (No. (%))310 (32.8)204 (26.9)
 60+ (No. (%))420 (44.4)392 (51.8)
Education
 High school or less (No. (%))143 (15.1)105 (13.9)
 Some college (No. (%))303 (32.1)231 (30.6)
 College/post-graduate (No. (%))498 (52.8)418 (55.4)
Income*
 < $35 K (No. (%))161 (18.3)141 (20.2)
 $45–55 K (No. (%))203 (23.1)186 (26.6)
 $55–85 K (No. (%))216 (24.6)149 (21.3)
 $85 K+ (No. (%))298 (33.9)223 (31.9)
Employed (No. (%)557 (58.9)417 (55.2)
White (No. (%))*743 (79.9)582 (78.0)
Hispanic (No. (%))*53 (5.8)40 (5.5)
Back-related function (RMDQ; 0–23 scales) mean (SD)11.8 (6.3)11.8 (6.1)
Back pain severity (0–10 scales; mean (SD))5.4 (2.5)5.5 (2.5)
STarT back risk group
 Low (No. (%))392 (41.5)305 (40.3)
 Medium (No. (%))348 (36.8)286 (37.8)
 High (No. (%))205 (21.7)165 (21.8)
Duration of current episode of LBP§
 < 3 months (%)186 (56,4)153 (56.0)
 3–12 months (%)58 (17.6)47 (17.2)
 12 months (%)86 (26.0)73 (26.7)
Hrs. of work missed past week due to LBP (mean (SD))4.4 (10.4)3.6 (8.9)
Effect of LBP on work in past week (0–10; mean (SD))3.0 (2.9)3.0 (2.7)
Leg pain in leg (No. (%))457 (48.4)360 (47.7)
Anxiety (GAD-7; mean (SD))4.2 (4.6)4.4 (4.6)
Depression (PHQ-8; mean (SD))6.1 (5.4)6.2 (5.3)
Self-efficacy (PSEQ; mean (SD))44.4 (13.3)45.0 (12.7)
Fear of movement (TKS; mean (SD))39.7 (10.1)39.4 (10.3)
Used medications for back pain in past week (No. (%))735 (77.8)570 (75.5)
Used narcotics for back pain in past week (No. (%))104 (31.5)76 (27.8)
Abbreviations: LBP, low back pain; GAD, generalized anxiety disorder; PHQ, patient health questionnaire; PSEC, patient self-efficacy questionnaire; TSK, Tampa Scale for Kinesiophobia; RMDQ, Roland-Morris Disability Questionnaire

*Missing data: income and pain duration (7%), race and Hispanic (3%), and hours of work missed (1%). All other variables had < 1% missing

Higher scores indicate greater dysfunction

Higher scores indicate greater pain severity

§Pain duration was measured only during the pre-implementation period, resulting in smaller sample sizes than for the other measures